Germany· DE-A57-1cc5323a505a0601
Ceftazidim Dr. Eberth
A medicinal product containing ceftazidime pentahydrate, registered in Germany by Dr. Friedrich Eberth Arzneimittel Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ceftazidime Pentahydrate
- Manufacturer
- Dr. Friedrich Eberth Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftazidime pentahydrate in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALTECIMMedochemie Ltd., Limassol
- United KingdomCeftazidime 1g powder for solution for injection vialsAspire Pharma Ltd
- FinlandCeftazidim ActavisActavis Group PTC ehf
- SpainALFAGEM 1 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIONMedochemie Limited
- BelgiumCeftazidim Fresenius Kabi 1000 mgFresenius Kabi
- FranceCEFTAZIDIME ARROW 1 g, poudre pour solution injectable (IM,IV)EUGIA PHARMA (MALTA) (MALTE)
- United StatesCeftazidimeSagent Pharmaceuticals
- ItalyCEFTAZIDIMA ALMUSALMUS S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ceftazidim Aptapharma, Ceftazidim Hameln
- Belgium · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Bulgaria · Алфагем, Зидимцеф
- Cyprus · Alfagem, Cezid
- Czechia · Altecim, Ceftazidim Aptapharma
- Denmark · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Estonia · Altecim, Ceftazidime Fresenius Kabi
- Spain · Alfagem, Ceftazidima Kabi
- Finland · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- France · Ceftazidime Arrow, Ceftazidime Enfants Et Nourrissons Panpharma
- United Kingdom (Northern Ireland) · Ceftazadime, Ceftazidime Cox Pharmaceutical
- Greece · Alfagem, Ceftaridem
- Croatia · Altecim, Cefaz
- Hungary · Ceftazidim Aptapharma, Ceftazidim Kabi
- Ireland · Ceftazidime Hameln, Ceftazidime Hikma Farmacêutica
- Iceland · Ceftazidim Fresenius Kabi, Ceftazidima Normon
- Italy · Ceftazidima Almus, Ceftazidima Astro-Pharma
- Lithuania · Biotum, Ceftazidime Kabi
- Luxembourg · Ceftazidim Fresenius Kabi, Glazidim
- Latvia · Ceftazidime Fresenius Kabi, Ceftazidime Mip
- Malta · Alfagem, Ceftazidima Fresenius
- Netherlands · Ceftazidim (Im/Iv) Mip, Ceftazidim (Iv) Mip
- Norway · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Poland · Biotum, Ceftazidim Aptapharma
- Portugal · Alfagem, Ceftazidima Accord
- Romania · Alfagem, Ceftamil
- Sweden · Ceftazidim Hameln, Fortum
- Slovenia · Ceftazidim Aptapharma, Ceftazidim Kabi
- Slovakia · Ceftazidim Ash, Ceftazidim Hameln
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7438179-0759-4c0b-8cb2-3cfbf1c75cdb GET /v1/drugs/d7438179-0759-4c0b-8cb2-3cfbf1c75cdb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use ,Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ceftazidime Pentahydrate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ceftazidime pentahydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.